bariatric surgery and glp 1 How Medical Weight Loss Methods Compare vs GLP-1s #GastricSleeve #WeightLossTips #surgery #glp1 Efficacy of the Glucagon-Like Peptide-1

Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

GLP-1 receptor (GLP-1R) agonists, like liraglutide, have shown analgesic effects by modulating pain hypersensitivity in animal models of inflammatory and neuropathic pain

No subscription

It is not approved for any of these yet, but the intent is clearly broader metabolic health, not just weight loss

New data is shedding light on a potential link between GLP-1 receptor agonists and long-term vision outcomes, with findings suggesting these therapies may be associated with a lower risk of legal blindness in patients with type 2 diabetes

Most users see best results with consistent, daily use over 812 weeks